The effect of viral inoculum level and host age on disease incidence, disease severity, and mortality in a murine model of ocular HSV-1 infection
- PMID: 7768106
- DOI: 10.3109/02713689508999926
The effect of viral inoculum level and host age on disease incidence, disease severity, and mortality in a murine model of ocular HSV-1 infection
Abstract
It has been previously shown that the strain of virus, immune competence of the host, and innate resistance of the host have an effect on the severity of ocular disease induced by topical infection with herpes simplex virus type 1 (HSV-1). This study has expanded on earlier work by examining the effect of virus inoculum and host age on mortality, incidence of ocular disease, and severity of ocular disease. BALB/c mice were infected with inocula ranging from 2 x 10(3) to 1 x 10(6) pfu of HSV-1 strain CJ394. The most significant effect of variation in the inoculum was on the percent of mice developing disease. Increasing the inoculum resulted in significantly increased disease incidence, but at 5 x 10(3) pfu/mouse or higher, there was little difference in disease severity in those animals exhibiting symptoms. Decreasing host age also resulted in a significant increase in the incidence of ocular disease, but the dependence of disease severity on host age varied with the symptom being scored. In animals exhibiting disease, the peak severity of stromal keratitis and vascularization of the cornea were unaffected by host age. However, the severity of blepharitis was significantly reduced in older mice. Increasing host age also resulted in increased resistance to encephalitis. Three to four-week old mice were very susceptible to encephalitis (100% mortality), while only 20% of 4-5 week old mice died by day 15 post-infection. Mice older than 5 weeks were completely resistant to lethal encephalitis after corneal infection.
Similar articles
-
Effects of CXCR3 signaling on development of fatal encephalitis and corneal and periocular skin disease in HSV-infected mice are mouse-strain dependent.Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4162-70. doi: 10.1167/iovs.07-0261. Invest Ophthalmol Vis Sci. 2007. PMID: 17724202
-
Involvement of LFA-1 and ICAM-1 in the herpetic disease resulting from HSV-1 corneal infection.Curr Eye Res. 1995 Jan;14(1):55-62. doi: 10.3109/02713689508999914. Curr Eye Res. 1995. PMID: 7720405
-
Application of FGF-2 to modulate herpetic stromal keratitis.Curr Eye Res. 2006 Dec;31(12):1021-8. doi: 10.1080/02713680601038824. Curr Eye Res. 2006. PMID: 17169840
-
The role of viral and host genes in corneal infection with herpes simplex virus type 1.Exp Eye Res. 2005 May;80(5):607-21. doi: 10.1016/j.exer.2004.09.007. Exp Eye Res. 2005. PMID: 15862167 Review.
-
Management of herpes simplex virus stromal keratitis: an evidence-based review.Surv Ophthalmol. 2009 Mar-Apr;54(2):226-34. doi: 10.1016/j.survophthal.2008.12.004. Surv Ophthalmol. 2009. PMID: 19298901 Review.
Cited by
-
Evaluation of a peptidomimetic ribonucleotide reductase inhibitor with a murine model of herpes simplex virus type 1 ocular disease.Antimicrob Agents Chemother. 1996 May;40(5):1078-84. doi: 10.1128/AAC.40.5.1078. Antimicrob Agents Chemother. 1996. PMID: 8723444 Free PMC article.
-
The disc damage likelihood scale: reproducibility of a new method of estimating the amount of optic nerve damage caused by glaucoma.Trans Am Ophthalmol Soc. 2002;100:181-5; discussion 185-6. Trans Am Ophthalmol Soc. 2002. PMID: 12545692 Free PMC article.
-
Dendritic Cell Autophagy Contributes to Herpes Simplex Virus-Driven Stromal Keratitis and Immunopathology.mBio. 2015 Oct 27;6(6):e01426-15. doi: 10.1128/mBio.01426-15. mBio. 2015. PMID: 26507231 Free PMC article.
-
Herpes simplex virus-1 KOS-63 strain is virulent and causes titer-dependent corneal nerve damage and keratitis.Sci Rep. 2021 Feb 19;11(1):4267. doi: 10.1038/s41598-021-83412-9. Sci Rep. 2021. PMID: 33608598 Free PMC article.
-
Brain resistance to HSV-1 encephalitis in a mouse model.J Neurovirol. 2002 Jun;8(3):180-90. doi: 10.1080/13550280290049633. J Neurovirol. 2002. PMID: 12053273
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical